Search

  • HOME
  • Search
Editorial
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
Clin Mol Hepatol. 2024;30(2):150-153.   Published online February 22, 2024
View: 2511   Download: 71  Web of Science: 1  Crossref: 1
Correspondence
Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
Yee Hui Yeo, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):124-125.   Published online November 14, 2023
View: 1395   Download: 40  Crossref: 1
Review
1842
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):1-15.   Published online July 21, 2023
View: 6033   Download: 304  Web of Science: 7  Crossref: 8
1748
Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clin Mol Hepatol. 2023;29(Suppl):S32-S42.   Published online December 14, 2022
View: 10662   Download: 446  Web of Science: 91  Crossref: 117
Original Article
1814
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
Clin Mol Hepatol. 2023;29(3):721-732.   Published online March 22, 2023
View: 17004   Download: 1,512  Web of Science: 155  Crossref: 176
Snapshot
1783
Systemic therapy in advanced hepatocellular carcinoma
Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
Clin Mol Hepatol. 2023;29(2):516-519.   Published online February 20, 2023
View: 3857   Download: 164  Web of Science: 4  Crossref: 4
Original Article
1771
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Clin Mol Hepatol. 2023;29(2):453-464.   Published online February 1, 2023
View: 3666   Download: 120  Web of Science: 2  Crossref: 2
Review
1457
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Ju Dong Yang
Clin Mol Hepatol. 2019;25(4):335-343.   Published online March 29, 2019
View: 11096   Download: 246  Web of Science: 41  Crossref: 41
Reply to Correspondence
Complement proteins and liver diseases: A response to the correspondence
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
Received April 30, 2024  Accepted April 30, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0320    [Epub ahead of print]
View: 480   Download: 36
Editorial
Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine
Joseph C. Ahn, Ju Dong Yang
Received May 10, 2024  Accepted May 13, 2024  
View: 379   Download: 7
Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis
Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
Received June 25, 2024  Accepted June 29, 2024  
View: 259   Download: 15
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 980
TOTAL : 1939115
Close layer